That's great you're following the latest research! There have been some very promising advances for both Rett and Dravet syndromes.

For Dravet, a gene-regulation therapy called zorevunersen is showing sustained seizure reductions and improvements in other areas. You can even check out the Emperor trial site (https://www.emperorstudy.com/) for Phase 3 study info. For Rett, keep an eye on gene therapies from Taysha and Neurogene. Also, UCB is planning global trials of fintepla for Rett syndrome.

The ASCEND 2026 National Summit (https://www.rettsyndrome.org/event/ascend2026/) in June will have lots of research updates. Hope this helps!